KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 107 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $228,068 | +23.4% | 13,130 | 0.0% | 0.00% | – |
Q2 2023 | $184,870 | +33.8% | 13,130 | +2.3% | 0.00% | – |
Q1 2023 | $138,169 | -57.0% | 12,841 | -40.1% | 0.00% | – |
Q4 2022 | $321,186 | +4.0% | 21,441 | -10.8% | 0.00% | – |
Q3 2022 | $308,802 | +166.2% | 24,050 | +101.6% | 0.00% | – |
Q2 2022 | $116,000 | -2.5% | 11,928 | 0.0% | 0.00% | – |
Q1 2022 | $119,000 | -15.0% | 11,928 | 0.0% | 0.00% | – |
Q4 2021 | $140,000 | +3.7% | 11,928 | +0.8% | 0.00% | – |
Q3 2021 | $135,000 | -18.2% | 11,828 | 0.0% | 0.00% | – |
Q2 2021 | $165,000 | -25.3% | 11,828 | -1.1% | 0.00% | – |
Q1 2021 | $221,000 | +10.0% | 11,964 | +5.1% | 0.00% | – |
Q4 2020 | $201,000 | – | 11,383 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 2,474,561 | $42,983,125 | 5.17% |
Rubric Capital Management LP | 3,077,449 | $53,455,289 | 2.00% |
Parkman Healthcare Partners LLC | 509,810 | $8,855,400 | 1.62% |
TANG CAPITAL MANAGEMENT LLC | 600,000 | $10,422,000 | 1.47% |
AlphaCentric Advisors LLC | 110,000 | $1,910,700 | 1.08% |
Lion Point Capital, LP | 130,691 | $2,270,103 | 1.01% |
RICE HALL JAMES & ASSOCIATES, LLC | 650,366 | $11,296,857 | 0.72% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 185,853 | $3,228,267 | 0.53% |
ADVISORY RESEARCH INC | 204,098 | $3,545,182 | 0.49% |
Jackson Creek Investment Advisors LLC | 65,607 | $1,140 | 0.48% |